Albany, NY -- (SBWIRE) -- 04/11/2014 -- Cystic Fibrosis (CF), also known as mucoviscidosis, is a genetic disorders that affects the lungs, pancreas, liver and intestine. It is characterized by abnormal transport of chloride and sodium across the epithelium. It leads to secretion of stick and thick mucus, which obstruct pancreatic enzyme activity in the body.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/cystic-fibrosis-therapeutics.html
Global market of CF therapeutics is rapidly growing, due to increased innovations and introduction of new drugs for the treatment of the disease. Rising prevalence of CF among large population base followed by increased R&D investment are also supporting factor for the growth of market. High price of CF modulators and complexity of pathophysiology are some of the factors that hinder the growth of this market. Development of new therapeutic techniques and development of safe anti-inflammatory therapies for the treatment of the disease are major opportunities for the market. Some of the major drug brands for the treatment of CF are Tobramycin, Podhaler, Colistimethate sodium, Colobrethe and Cayston.
The market of CF therapeutics is focused on epidemiology of disease in major countries of the world, such as the U.S., France, Germany and the U.K. The market is segmented on the basis of age, sex and mutation. Some of the major players operating in the market are Pari Pharma, AstraZeneca and Vertex Pharmaceuticals.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1829
90 State Street,
Albany NY - 12207
Browse Market Research Blogs: